Jazzou News

1. Cure Even the Most Severe Yeast Infection At Home Fast with Latest Home Remedy Treatment

It has been reported by www.treatmentsforyeastinfection.com that more people are looking for home remedies to treat yeast infections. In fact many have even cured the most severe cases this way. A guide called Natural Cure for Yeast Infection has...

02/09/2010 | 235 Hits | Print | PDF | Email | Read more...

2. Cellulite Treatment Free Trial Gel - Proven Alternative to Lipo Suction

Cellulean the new treatment for Cellulite is now available on a free trial. The proven formula available in liquid form which can be applied direct to problem parts of the body. The solution is said to reduce cellulite by 78% after only 30 days. ...

03/08/2010 | 138 Hits | Print | PDF | Email | Read more...

3. CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review --- Aarkstore Enterprise

CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review CordLife Pte. Ltd. (Cordlife) is a publicly held healthcare company engaged in collection, processing and storing cord blood stem cells to be used as potential source material...

27/07/2010 | 48 Hits | Print | PDF | Email | Read more...

4. China chinese patent drug processing industry Developments and trends

HTML clipboardChina chinese patent drug processing industry, 2010 report ( http://www.bharatbook.com/detail.asp?id=133776&rt=China-chinese-patent-drug-processing-industry-2010.html ) which provides China chinese patent drug processing Industry,...

27/07/2010 | 27 Hits | Print | PDF | Email | Read more...

5. China Medical Equipment & Supplies Mfg. Industry Profile - CIC368 --- Aarkstore Enterprise

Through a comparative analysis on the development of medical equipment & supplies mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the medical...

22/07/2010 | 40 Hits | Print | PDF | Email | Read more...

6. CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review --- Aarkstore Enterprise

CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review CellMetrix, Inc. (CellMetrix) is a medical technology company. It is focused on the development of automated laboratory systems and clinical testing applications that together...

22/07/2010 | 24 Hits | Print | PDF | Email | Read more...

7. CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review --- Aarkstore Enterprise

HTML clipboard CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review Summary CAS Medical Systems, Inc. (CASMED) is a medical device company engaged in designing, developing, manufacturing and marketing of innovative...

02/07/2010 | 49 Hits | Print | PDF | Email | Read more...

8. Calypte Biomedical Corporation CBMC - Financial and Strategic Analysis Review - Aarkstore Enterprise

HTML clipboard Calypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review Summary Calypte Biomedical Corporation (Calypte) is a diagnostic company engaged in the development, manufacture and marketing of in-vitro...

02/07/2010 | 43 Hits | Print | PDF | Email | Read more...

9. Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition

Despite the growing attention being paid to the world’s ageing population, children remain a significant consumer group that cannot be overlooked. Children aged between 5 and 14 represent around 9-12% of the total population in western Europe...

25/06/2010 | 138 Hits | Print | PDF | Email | Read more...

10. Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016

  GlobalData forecasts the global candidiasis market to grow at 5.9% annually for the next seven years to reach $2,386m by 2016. It was valued at $1,592m in 2009. This moderate growth will primarily be supported by an increase in the disease...

28/04/2010 | 59 Hits | Print | PDF | Email | Read more...

11. Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016

  GlobalData’s analysis suggests that the global chronic kidney disease (CKD) market was worth $13.3 billion in 2009. It is forecast to grow at a compound annual growth rate (CAGR) of 5.9% for the next seven years to reach $19.8 billion by...

09/03/2010 | 109 Hits | Print | PDF | Email | Read more...

12. Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016

  GlobalData estimated the Chronic Obstructive Pulmonary Disease (COPD) market to be worth $7.2 billion in 2009 and projects it to grow at a compound annual growth rate (CAGR) of 7.4% to reach $11.9 billion in 2016. The development of novel...

11/02/2010 | 296 Hits | Print | PDF | Email | Read more...

13. Children at Greater Risk for H1N1

A study of household transmission of the H1N1 pandemic flu has confirmed that children 18 and younger are more at risk than young adults and seniors.  

31/12/2009 | 72 Hits | Print | PDF | Email

14. Cold & Flu Health Center

Dec. 28, 2009 -- H1N1 influenza poses a special risk to pregnant women and new mothers, but life-threatening treatment delays are common in this group, a new study confirms.

29/12/2009 | 73 Hits | Print | PDF | Email